Gosall (Bilastine)

Gosall is indicated for the treatment of allergic conjunctivitis, a condition characterized by eye redness, itching, and watery discharge caused by exposure to allergens.

• Relief of ocular itching caused by seasonal or perennial allergens.
• Reduction of redness and swelling of the conjunctiva.
• Decrease in watery or mucoid discharge associated with allergic eye reactions.
• Prevention of symptom recurrence when used as directed during allergen exposure periods.
• Adjunctive therapy for patients who have inadequate response to non‑pharmacologic measures such as avoidance.

The safety profile of Gosall reflects the pharmacology of bilastine when applied to the eye. Most patients experience mild, transient events, while rare serious reactions may require medical attention.

Common

• Transient burning or stinging sensation upon instillation.
• Mild eye irritation or foreign‑body sensation.
• Temporary blurred vision lasting a few minutes.

Serious

• Persistent ocular redness or swelling unresponsive to treatment.
• Severe allergic reaction with eyelid edema or hives.
• Vision changes such as sudden loss of visual acuity.

Before using Gosall, certain precautions should be considered to ensure safe and effective therapy.

• Verify that the product is intended for ocular use and not for systemic administration.
• Do not use if you have a known hypersensitivity to bilastine or any excipients in the formulation.
• Consult an eye care professional if you wear contact lenses; remove lenses before instillation and wait before reinserting.
• Use the medication only for the duration prescribed; prolonged use without supervision is not recommended.
• Pregnant or breastfeeding individuals should discuss potential risks with their healthcare provider.
• Keep the eye drops out of reach of children and store at room temperature away from direct sunlight.

Gosall may interact with other substances that affect histamine pathways or ocular drug absorption.

Avoid

• Concurrent use of other topical antihistamine eye drops, which can increase the risk of local irritation.
• Administration of ophthalmic vasoconstrictors that may mask signs of infection.

Use with caution

• Systemic antihistamines or mast‑cell stabilizers, as combined effects on H1 receptors could alter symptom control.
• Eye medications containing preservatives that may exacerbate irritation.
• Herbal supplements such as St. John’s wort, which can influence drug metabolism pathways.